spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Protecta 

 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Jan 2016
Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Oct 2015
Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Feb 2014
Zocere Appoints Zavitz as Chief Scientific Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 22 Oct 2013
Antibe Therapeutics Announces Grant of Stock Options and an Addition to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 31 May 2012
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
Devices Cardiology
 HSMN NewsFeed - 30 Jan 2012
Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices
Devices Cardiology FDA
 HSMN NewsFeed - 28 Mar 2011
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
Devices Cardiology FDA
 HSMN NewsFeed - 17 Jun 2010
Medtronic Announces European Launch of Protecta Portfolio with SmartShock Technology Shown to Significantly Reduce Inappropriate Shocks
Devices Cardiology
 HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008
Devices Wound Care
 HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Mar 2008
Novelos Therapeutics Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Nov 2007
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
APT Pharmaceuticals Closes New $22 Million Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Sep 2007
Novelos Therapeutics Elects Dr. Stephen Hill to Serve as Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2007
Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2007
AtheroGenics Announces Promotion of Charles A. Deignan to Vice President of Finance and Administration
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2007
FDA Clears Humanetics' IND Filing to Commence Clinical Studies on New Radiation Countermeasure
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2006
Cleveland BioLabs President and CEO Provides Update on Clinical and Corporate Developments
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jul 2006
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2006
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2006
Novelos Therapeutics Finalizes SPA with FDA for Phase 3 Trial in Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 May 2006
AtheroGenics Names Brian Blakey as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2006
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2006
AtheroGenics Announces Promotions of Three Senior Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2006
New Performance Data Presented at ISCT Demonstrates ThermoGenesis' AutoXpress(TM) System (AXP) Efficiently Separates Stem Cells From Cord Blood
Devices Regenerative Medicine
Return to NewsFeed  

 Additional items found! 48

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 48 additional stories matching:
Protecta
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.